by Laurel Manke | Oct 16, 2025 | 3PL, Cold Chain, Ryan Oppel
When Risk Becomes Reality In specialty pharma, every degree matters—and every delay has a cost. As products become more targeted and high-value—such as cell therapies, controlled medications, and rare biologics—the demand for secure, real-time-monitored cold chain...